Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting.

Kisilevsky R, Raimondi S, Bellotti V.

Front Mol Biosci. 2016 May 9;3:17. doi: 10.3389/fmolb.2016.00017. eCollection 2016. Review.

2.

Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review.

Zhang J, Shao C, Zhu J, Tu C, Lv X.

Exp Ther Med. 2016 May;11(5):1809-1811. Epub 2016 Feb 19.

3.

Effects of Carbon Nanotube Environmental Dispersion on an Aquatic Invertebrate, Hirudo medicinalis.

Girardello R, Tasselli S, Baranzini N, Valvassori R, de Eguileor M, Grimaldi A.

PLoS One. 2015 Dec 4;10(12):e0144361. doi: 10.1371/journal.pone.0144361. eCollection 2015.

4.

Induced Dipole-Dipole Interactions Influence the Unfolding Pathways of Wild-Type and Mutant Amyloid β-Peptides.

Lemkul JA, Huang J, MacKerell AD Jr.

J Phys Chem B. 2015 Dec 24;119(51):15574-82. doi: 10.1021/acs.jpcb.5b09978. Epub 2015 Dec 15.

5.

The Effects of Lipid Membranes, Crowding and Osmolytes on the Aggregation, and Fibrillation Propensity of Human IAPP.

Gao M, Winter R.

J Diabetes Res. 2015;2015:849017. doi: 10.1155/2015/849017. Epub 2015 Oct 25. Review.

6.

Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain.

Brumshtein B, Esswein SR, Salwinski L, Phillips ML, Ly AT, Cascio D, Sawaya MR, Eisenberg DS.

Elife. 2015 Nov 18;4:e10935. doi: 10.7554/eLife.10935.

7.

Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.

Macedo B, Sant'Anna R, Navarro S, Cordeiro Y, Ventura S.

Microb Cell Fact. 2015 Nov 4;14:174. doi: 10.1186/s12934-015-0361-y.

8.

Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis.

Berchowitz LE, Kabachinski G, Walker MR, Carlile TM, Gilbert WV, Schwartz TU, Amon A.

Cell. 2015 Oct 8;163(2):406-18. doi: 10.1016/j.cell.2015.08.060. Epub 2015 Sep 24.

PMID:
26411291
9.

Mechanisms of amyloid formation revealed by solution NMR.

Karamanos TK, Kalverda AP, Thompson GS, Radford SE.

Prog Nucl Magn Reson Spectrosc. 2015 Aug;88-89:86-104. doi: 10.1016/j.pnmrs.2015.05.002. Epub 2015 May 27. Review.

10.

Generating new prions by targeted mutation or segment duplication.

Paul KR, Hendrich CG, Waechter A, Harman MR, Ross ED.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8584-9. doi: 10.1073/pnas.1501072112. Epub 2015 Jun 22.

11.

Toxic species in amyloid disorders: Oligomers or mature fibrils.

Verma M, Vats A, Taneja V.

Ann Indian Acad Neurol. 2015 Apr-Jun;18(2):138-45. doi: 10.4103/0972-2327.144284. Review.

12.

Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.

Wall JS, Martin EB, Richey T, Stuckey AC, Macy S, Wooliver C, Williams A, Foster JS, McWilliams-Koeppen P, Uberbacher E, Cheng X, Kennel SJ.

Molecules. 2015 Apr 27;20(5):7657-82. doi: 10.3390/molecules20057657.

13.

Untangling the etiology of ascites.

Lopez-Molina M, Shiani AV, Oller KL.

Am J Case Rep. 2015 Apr 6;16:202-5. doi: 10.12659/AJCR.893012.

14.

Mechanism of initiation of aggregation of p53 revealed by Φ-value analysis.

Wang G, Fersht AR.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2437-42. doi: 10.1073/pnas.1500243112. Epub 2015 Feb 9.

15.

Indexing amyloid peptide diffraction from serial femtosecond crystallography: new algorithms for sparse patterns.

Brewster AS, Sawaya MR, Rodriguez J, Hattne J, Echols N, McFarlane HT, Cascio D, Adams PD, Eisenberg DS, Sauter NK.

Acta Crystallogr D Biol Crystallogr. 2015 Feb;71(Pt 2):357-66. doi: 10.1107/S1399004714026145. Epub 2015 Jan 23.

16.

Feasibility of β-sheet breaker peptide-H102 treatment for Alzheimer's disease based on β-amyloid hypothesis.

Lin LX, Bo XY, Tan YZ, Sun FX, Song M, Zhao J, Ma ZH, Li M, Zheng KJ, Xu SM.

PLoS One. 2014 Nov 5;9(11):e112052. doi: 10.1371/journal.pone.0112052. eCollection 2014.

17.

A model of protein association based on their hydrophobic and electric interactions.

Mozo-Villarías A, Cedano J, Querol E.

PLoS One. 2014 Oct 17;9(10):e110352. doi: 10.1371/journal.pone.0110352. eCollection 2014.

18.

Recent advances in transthyretin amyloidosis therapy.

Ueda M, Ando Y.

Transl Neurodegener. 2014 Sep 13;3:19. doi: 10.1186/2047-9158-3-19. eCollection 2014. Review.

19.

Ion mobility spectrometry: A personal view of its development at UCSB.

Bowers MT.

Int J Mass Spectrom. 2014 Sep 15;370:75-95.

20.

Formation of amyloid fibers by monomeric light chain variable domains.

Brumshtein B, Esswein SR, Landau M, Ryan CM, Whitelegge JP, Phillips ML, Cascio D, Sawaya MR, Eisenberg DS.

J Biol Chem. 2014 Oct 3;289(40):27513-25. doi: 10.1074/jbc.M114.585638. Epub 2014 Aug 19.

Items per page

Supplemental Content

Write to the Help Desk